Article Advocacy
IFPA's resources for universal health coverageBecause health is a human right
Advocacy toolkit for universal health coverage
12 December 2019
By IFPA

The first High-level meeting on universal health coverage (UHC) was held on 23 September 2019 during the General Assembly of the United Nations, where United Nation’s Member States unanimously approved the political declaration on UHC.
The political declaration on UHC can be used to advocate for psoriatic disease as UHC is a broad concept comprehensive of multiple issues related to psoriatic disease:
- Noncommunicable diseases
- Mental health
- Disabilities
- Primary care
- Financial hardship
- Access to medicines
- Health workforce
The political declaration on UHC is a precious new tool at our disposal and can be used together with the WHO Resolution on Psoriasis and the WHO Global report on Psoriasis to advocate for improving the lives of people living with psoriatic disease worldwide.
Access the toolkit on psoriatic disease and universal health coverage
More resources on universal health coverage
Article Advocacy
IFPA Coalition's statement on COVID-19tool Advocacy
Fact-sheet on universal health coverage and psoriatic disease
report Advocacy, Reports
Article Advocacy
Quality healthcare and people in focusRelated content
tool Advocacy, IFPA Forum
Collaborative research for psoriatic disease
tool Advocacy, Comorbidities, IFPA Forum
Psoriatic disease and non-communicable diseases
tool Universal Health Coverage, Advocacy, Care and Treatment, IFPA Forum
Access to care and early detection of psoriatic disease
report Advocacy, Comorbidities, Living with Psoriatic Disease, Care and Treatment, Reports, IFPA Forum
Cost of treatment unbearable for patients: PA Ghana urges capture of psoriasis under NHIS
report Advocacy, World Psoriasis Day, Comorbidities, Stigma, Living with Psoriatic Disease, About Psoriatic Disease

Article Advocacy
IFPA at WHA77Article Advocacy, Real Stories
“Before the resolution, many people did not fully understand that psoriasis is a serious complex systemic disease”